97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

29 trials found

diseases per page:

Showing 1 to 10 of 29 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05684484 (ClinicalTrials.gov)	February 1, 2023	26/12/2022	Role of Roflumilast in Ulcerative Colitis	Clinical Study to Evaluate the Possible Efficacy and Safety of Roflumilast in Patients With Ulcerati ...	Ulcerative Colitis	Drug: Roflumilast 500 Ug ORAL TABLET [Daliresp];Drug: corticosteroids+immune suppressive +amino salic ...	Tanta University	NULL	Not yet recruiting	15 Years	80 Years	All	52	Phase 4	NULL
2	NCT04999228 (ClinicalTrials.gov)	November 1, 2021	5/8/2021	Top Down Versus Step up in Pediatric Ulcerative Colitis	First-line Treatment With Infliximab Versus Corticosteroidsin Children With Newly Diagnosed Moderate ...	Ulcerative Colitis;Infliximab;Children	Drug: Infliximab;Drug: Corticosteroids	Children's Hospital of Fudan University	NULL	Recruiting	6 Years	18 Years	All	40	Phase 4	China
3	NCT04879966 (ClinicalTrials.gov)	May 17, 2021	6/5/2021	A Cohort Study Comparing IFX to CS for Moderate to Severe UC	A Multicenter Prospective Cohort Study Comparing Infliximab to Corticosteroidsfor Moderate to Severe ...	Moderate to Severe Ulcerative Colitis	Drug: Infliximab;Drug: Corticosteroid	Sixth Affiliated Hospital, Sun Yat-sen University	NULL	Recruiting	18 Years	70 Years	All	342		China
4	NCT03942861 (ClinicalTrials.gov)	February 21, 2019	25/4/2019	Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroid ...	Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroid ...	Ulcerative Colitis;Ultrasound Therapy; Complications	Drug: Solu-Medrol	Copenhagen University Hospital at Herlev	NULL	Recruiting	18 Years	70 Years	All	50		Denmark
5	EUCTR2017-000937-30-AT (EUCTR)	22/02/2018	03/01/2018	Investigate the efficacy and safety of study drug ABX464 50 mg once daily versus placebo with patien ...	A Phase IIa study to evaluate the safety and efficacy of ABX464 50 mg once daily versus Placebo in s ...	Moderate to severe Ulcerative Colitis. MedDRA version: 20.1;Level: LLT;Classification code 10066678; ...	Product Code: ABX464 INN or Proposed INN: ABX464 Other descriptive name: ABX464	ABIVAX	NULL	Not Recruiting			Female: yes Male: yes	30	Phase 2	France;Hungary;Spain;Poland;Belgium;Austria;Germany
6	EUCTR2017-000937-30-PL (EUCTR)	13/12/2017	25/09/2017	Investigate the efficacy and safety of study drug ABX464 50 mg once daily versus placebo with patien ...	A Phase IIa study to evaluate the safety and efficacy of ABX464 50 mg once daily versus Placebo in s ...	Moderate to severe Ulcerative Colitis. MedDRA version: 20.1;Level: LLT;Classification code 10066678; ...	Product Code: ABX464 INN or Proposed INN: ABX464 Other descriptive name: ABX464	ABIVAX	NULL	Not Recruiting			Female: yes Male: yes	30	Phase 2	France;Hungary;Spain;Belgium;Poland;Austria;Germany
7	EUCTR2017-000937-30-ES (EUCTR)	27/11/2017	10/10/2017	Investigate the efficacy and safety of study drug ABX464 50 mg once daily versus placebo with patien ...	A Phase IIa study to evaluate the safety and efficacy of ABX464 50 mg once daily versus Placebo in s ...	Moderate to severe Ulcerative Colitis. MedDRA version: 20.0;Level: LLT;Classification code 10066678; ...	Product Code: ABX464 INN or Proposed INN: ABX464 Other descriptive name: ABX464	ABIVAX	NULL	Not Recruiting			Female: yes Male: yes	30	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	France;Hungary;Poland;Belgium;Spain;Austria;Germany
8	EUCTR2017-000937-30-FR (EUCTR)	07/11/2017	19/09/2017	Investigate the efficacy and safety of study drug ABX464 50 mg once daily versus placebo with patien ...	A Phase IIa study to evaluate the safety and efficacy of ABX464 50 mg once daily versus Placebo in s ...	Moderate to severe Ulcerative Colitis. MedDRA version: 20.0;Level: LLT;Classification code 10066678; ...	Product Code: ABX464 INN or Proposed INN: ABX464 Other descriptive name: ABX464	ABIVAX	NULL	Not Recruiting			Female: yes Male: yes	30	Phase 2	France;Hungary;Spain;Poland;Belgium;Austria;Germany
9	EUCTR2016-001170-15-ES (EUCTR)	19/10/2017	02/08/2017	Intravenous corticosteroids in moderate ulcerative colitis	Efficacy of high-dose corticosteroid pulses added to conventional oral corticosteroid course in comp ...	Moderate flares of Ulcerative Colitis;Therapeutic area: Diseases [C] - Digestive System Diseases [C0 ...	Trade Name: Urbason INN or Proposed INN: methylprednisolone Other descriptive name: METHYLPREDNISOLONE ...	GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis ulcerosa)	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	148	Phase 4	Spain
10	EUCTR2017-000937-30-DE (EUCTR)	10/10/2017	25/09/2017	Investigate the efficacy and safety of study drug ABX464 50 mg once daily versus placebo with patien ...	A Phase IIa study to evaluate the safety and efficacy of ABX464 50 mg once daily versus Placebo in s ...	Moderate to severe Ulcerative Colitis. MedDRA version: 20.1;Level: LLT;Classification code 10066678; ...	Product Code: ABX464 INN or Proposed INN: ABX464 Other descriptive name: ABX464	ABIVAX	NULL	Not Recruiting			Female: yes Male: yes	30	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	France;Hungary;Spain;Poland;Belgium;Austria;Germany

First Previous1 2 3Next Last